The Stroke Priority Setting Partnership is being guided by a Steering Group. Members include people affected by stroke, health and social care professionals, and those in supporting roles. Where two people are named for one organisation, they are sharing one place.
Over 3500 delegates attended the 2nd European Stroke Organisation Conference (ESOC 2016) today in Barcelona. Today’s program included teaching courses, scientific presentations, an official welcome from the ESOC President Professor Kennedy Lees and from Professor Angel Chamorro, and presentations from major clinical trials.
We’re finding out what questions in stroke research are the most important to people affected by stroke, and to the healthcare professionals that work with them.
The process that we're going through has been developed by the James Lind Alliance, and it's called a Priority Setting Partnership (PSP).
The first day of the European Stroke Organisation Conference (ESOC) 2017 in Prague included some truly inspiring scientific sessions. These included reporting from the DAWN study which suggests that more patients could be able to receive mechanical thrombectomy after stroke.
The International Stroke Conference (ISC) is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take homes from our International Development Officer, Sarah Belson.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.
Two new research studies were published today, supporting the use of thrombectomy (mechanical retrieval of clots in the brain) for the treatment of large ischaemic strokes.
UK Stroke Forum 2016 took place from Monday to Wednesday (28-30 November) at the ACC in Liverpool. UK Stroke Forum is the largest multidisciplinary stroke event in the UK, attracting over 1400 delegates from across the stroke care pathway.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Disease of the chest portion of the largest artery in the body (the aorta), is known as thoracic aortic disease (TAD). The number of people experiencing TAD is increasing. This study is investigating how to make thoracic endovascular aortic stenting (TEVAR), the preferred method of treating TAD, safer by using extra protection devices.